(Q36874385)

English

Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease

scientific article published on August 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease (English)

1 reference

Europe PubMed Central

16 August 2017

author name string

Spiller R

1

1 reference

Europe PubMed Central

16 August 2017

publication date

1 August 2007

1 reference

Europe PubMed Central

16 August 2017

Neurogastroenterology and Motility

1 reference

Europe PubMed Central

16 August 2017

19 Suppl 2

1 reference

Europe PubMed Central

16 August 2017

25-31

1 reference

Europe PubMed Central

16 August 2017

Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00965.X

21 January 2018

Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00965.X

21 January 2018

Endogenous adenosine differentially modulates 5-hydroxytryptamine release from a human enterochromaffin cell model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00965.X

21 January 2018

Distinct 5-HT receptors mediate the peristaltic reflex induced by mucosal stimuli in human and guinea pig intestine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00965.X

21 January 2018

Effect of 5-hydroxytryptamine on gastrointestinal motility in conscious guinea-pigs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00965.X

21 January 2018

Serotonin stimulates migrating myoelectric complex via 5-HT3-receptors dependent on cholinergic pathways in rat small intestine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00965.X

21 January 2018

Effect of MKC-733, a 5-HT receptor partial agonist, on bowel motility and symptoms in subjects with constipation: an exploratory study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00965.X

21 January 2018

Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00965.X

21 January 2018

Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00965.X

21 January 2018

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00965.X

21 January 2018

Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00965.X

21 January 2018

Enteroendocrine cells and 5-HT availability are altered in mucosa of guinea pigs with TNBS ileitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00965.X

21 January 2018

Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00965.X

21 January 2018

Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00965.X

21 January 2018

Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00965.X

21 January 2018

Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00965.X

21 January 2018

Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00965.X

21 January 2018

Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00965.X

21 January 2018

Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00965.X

21 January 2018

Identifiers

10.1111/J.1365-2982.2007.00965.X

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36874385&oldid=2133740524"